Aflac Incorporated (AFL)

NYSE: AFL · Real-Time Price · USD
116.16
+0.68 (0.59%)
At close: May 12, 2026, 4:00 PM EDT
116.28
+0.12 (0.10%)
After-hours: May 12, 2026, 4:31 PM EDT
Market Cap59.12B +0.2%
Revenue (ttm)18.11B +7.2%
Net Income4.64B +29.0%
EPS8.81 +36.7%
Shares Out 508.98M
PE Ratio13.11
Forward PE16.06
Dividend$2.44 (2.10%)
Ex-Dividend DateMay 20, 2026
Volume2,161,531
Open115.88
Previous Close115.48
Day's Range114.42 - 116.68
52-Week Range96.95 - 119.32
Beta0.62
AnalystsHold
Price Target110.83 (-4.59%)
Earnings DateApr 29, 2026

About AFL

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. It operates in two segments, Aflac Japan and Aflac U.S. The Aflac Japan segment offers cancer, medical, nursing care, whole life, and GIFT insurance products, as well as WAYS and child endowment, and Tsumitasu insurance products in Japan. Its Aflac U.S. segment provides accident, disability, cancer, critical illness, hospital indemnity, dental, vision, and life insurance products in the United States. The company also provides hearing, final ... [Read more]

Sector Financials
Founded 1955
Employees 12,716
Stock Exchange NYSE
Ticker Symbol AFL
Full Company Profile

Financial Performance

In 2025, Aflac's revenue was $17.16 billion, a decrease of -9.31% compared to the previous year's $18.93 billion. Earnings were $3.65 billion, a decrease of -33.01%.

Financial Statements

Analyst Summary

According to 12 analysts, the average rating for AFL stock is "Hold." The 12-month stock price target is $110.83, which is a decrease of -4.59% from the latest price.

Price Target
$110.83
(-4.59% downside)
Analyst Consensus: Hold
Stock Forecasts

News

Aflac Transcript: AGM 2026

Shareholders approved all director nominees, say-on-pay, and auditor appointment by wide margins, while rejecting the independent board chairman proposal. Share buybacks remain opportunistic, and board succession planning continues.

8 days ago - Transcripts

Aflac price target raised to $104 from $102 at Mizuho

Mizuho analyst Yaron Kinar raised the firm’s price target on Aflac (AFL) to $104 from $102 and keeps an Underperform rating on the shares.

8 days ago - TheFly

Aflac opens new South Portland office to support Maine Paid Family and Medical Leave Program

Company brings services closer to home for more than 500,000 workers COLUMBUS, Ga., May 1, 2026 /PRNewswire/ -- Working with the Maine Department of Labor and the state's Paid Family Medical Leave (PF...

11 days ago - PRNewsWire

Aflac price target lowered to $125 from $130 at Piper Sandler

Piper Sandler lowered the firm’s price target on Aflac (AFL) to $125 from $130 and keeps an Overweight rating on the shares. The firm notes the company reported a miss…

11 days ago - TheFly

Aflac CEO Dan Amos on building an American success story

Aflac CEO Dan Amos reflects on the company's rise from humble Southern roots to a $60 billion powerhouse — and the bold bet that defined his career: a “damn duck.”

11 days ago - CNBC Television

Aflac Earnings Call Transcript: Q1 2026

Q1 2026 saw strong sales growth in Japan (+25.5%) and steady U.S. performance, with adjusted EPS up 6.6% year-over-year. Capital ratios remain robust, $1.3 billion was returned to shareholders, and new reinsurance initiatives in Japan signal future growth potential.

12 days ago - Transcripts

Aflac price target lowered to $99 from $101 at Barclays

Barclays lowered the firm’s price target on Aflac (AFL) to $99 from $101 and keeps an Underweight rating on the shares.

12 days ago - TheFly

Aflac reports Q1 adjusted EPS $1.75, consensus $1.80

Reports Q1 revenue $4.3B, consensus $4.33B. Commenting on the company’s results, Aflac (AFL) Incorporated Chairman and Chief Executive Officer Daniel Amos stated: “Aflac delivered solid earnings for t...

12 days ago - TheFly

Aflac Incorporated Announces First Quarter 2026 Results

COLUMBUS, Ga., April 29, 2026 /PRNewswire/ -- Aflac Incorporated (NYSE: AFL) today reported its first quarter results.

13 days ago - PRNewsWire

Aflac recognizes 6 leaders as Check for Cancer Champions

This recognition is part of Aflac's broader Check for Cancer initiative to expand awareness of the importance of screening as the path for early detection COLUMBUS, Ga., April 29, 2026 /PRNewswire/ --...

13 days ago - PRNewsWire

Aflac files to sell 51.64M shares of common stock for holders

09:04 EDT Aflac (AFL) files to sell 51.64M shares of common stock for holders

19 days ago - TheFly

American Cancer Society names Aflac 2025 Corporate Partner of the Year

Award recognizes Aflac for demonstrating exceptional partnership, delivering meaningful impact in advancing shared lifesaving mission COLUMBUS, Ga., April 23, 2026 /PRNewswire/ -- Aflac Incorporated, ...

19 days ago - PRNewsWire

Aflac price target lowered to $102 from $107 at Mizuho

Mizuho lowered the firm’s price target on Aflac (AFL) to $102 from $107 and keeps an Underperform rating on the shares. The firm adjusted estimates and targets among its North…

4 weeks ago - TheFly

Aflac price target raised to $115 from $113 at Keefe Bruyette

Keefe Bruyette raised the firm’s price target on Aflac (AFL) to $115 from $113 and keeps a Market Perform rating on the shares.

4 weeks ago - TheFly

Aflac price target lowered to $114 from $116 at UBS

UBS lowered the firm’s price target on Aflac (AFL) to $114 from $116 and keeps a Neutral rating on the shares. The firm adjusted targets in the North American life…

4 weeks ago - TheFly

Aflac Incorporated to Release First Quarter Results and CFO Video Update on April 29, 2026 and Host Webcast on April 30, 2026

COLUMBUS, Ga., April 2, 2026 /PRNewswire/ -- Aflac Incorporated (NYSE: AFL) announced today that it will release first quarter 2026 financial results after the market closes on Wednesday, April 29, 20...

5 weeks ago - PRNewsWire

Half Of All Investors Are Bearish, Missing This Cheap Dividend Stock

Half of individual investors think the stock market will be lower six months from now. That's a level of bearishness that intrigues contrarians like us!

5 weeks ago - Forbes

Aflac Re Bermuda Ltd. Announces Reinsurance Transaction with Japan Post Insurance Company

COLUMBUS, Ga., March 31, 2026 /PRNewswire/ -- Aflac Incorporated (NYSE: AFL), the leading life and health insurer through its subsidiaries in Japan and the U.S., today announced that Aflac Re Bermuda ...

6 weeks ago - PRNewsWire

Aflac re-initiated with a Market Perform at Keefe Bruyette

Keefe Bruyette re-initiated coverage of Aflac (AFL) with a Market Perform rating and $113 price target The life insurance sector presents a mixed fundamental picture, and while companies have reduced…

6 weeks ago - TheFly

New long-term care rider from Aflac offers flexibility and added security

Aflac offers comprehensive long-term care solution for the workplace with inflation protection COLUMBUS, Ga., March 23, 2026 /PRNewswire/ -- The cost of long-term care continues to rise, making caregi...

7 weeks ago - PRNewsWire

Aflac celebrates 20 years as a World's Most Ethical Company

Only insurance company to appear on prestigious list every year since 2007 COLUMBUS, Ga., March 18, 2026 /PRNewswire/ -- Aflac Incorporated, the leading provider of supplemental health insurance in th...

7 weeks ago - PRNewsWire

This Stock Pays A ‘Secret' 8%+ Dividend (And Cashes In On AI)

There's a group of stocks out there that most people think yield just 2%—or less.

2 months ago - Forbes

Aflac price target raised to $118 from $109 at Wells Fargo

Wells Fargo analyst Elyse Greenspan raised the firm’s price target on Aflac (AFL) to $118 from $109 and keeps an Equal Weight rating on the shares. With guidance from most…

2 months ago - TheFly

Aflac Transcript: UBS Financial Services Conference 2026

Strong sales growth in both Japan and the U.S. was driven by innovative products, expanded distribution, and disciplined capital management. The company remains focused on organic growth, technology investment, and maintaining its leading brand reputation, with continued shareholder returns and strategic flexibility.

3 months ago - Transcripts

Aflac Earnings Call Transcript: Q4 2025

Q4 2025 saw strong adjusted earnings and robust sales growth in Japan, driven by new product launches, while the U.S. segment maintained solid premium growth and persistency. Capital deployment remained high, with record share repurchases and dividends, and guidance for 2026 remains stable.

3 months ago - Transcripts